Role of 5-ALA in improving extent of tumour resection in patients with Glioblastoma Multiforme
- PMID: 28955092
Role of 5-ALA in improving extent of tumour resection in patients with Glioblastoma Multiforme
Abstract
Goal of surgery for patients with Glioblastoma Multiforme (GBM) is gross total resection with no new neurological deficits. Surgical resection is often restricted due the difficulty in differentiating the tumour from surrounding normal brain using either naked eye, or standard intra-operative white light microscopy. GBM uptakes orally administered 5-ALA becomes fluorescent when viewed by a special light, and this property has been used to improve intra-operative tumour identification. This technique should therefore allow better extent of tumour resection. The hypothesis has been tested through several studies and even though most studies are of low quality, they strongly favour the use of 5- ALA in improving the extent of resection when compared to white light microscopy. A systematic review on the topic had a similar conclusion. Few studies have also hinted on a high false negative rate with the use of this technique..
Keywords: Glioblastoma, 5-ALA, Extent of Resection, Overall Survival..
Similar articles
-
Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.Neurosurgery. 2016 Apr;78(4):475-83. doi: 10.1227/NEU.0000000000001035. Neurosurgery. 2016. PMID: 26407129
-
5-aminolevulinic acid guidance during awake craniotomy to maximise extent of safe resection of glioblastoma multiforme.BMJ Case Rep. 2015 Jul 15;2015:bcr2014208575. doi: 10.1136/bcr-2014-208575. BMJ Case Rep. 2015. PMID: 26177997 Free PMC article.
-
Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.Eur J Surg Oncol. 2014 Mar;40(3):297-304. doi: 10.1016/j.ejso.2013.11.022. Epub 2013 Dec 19. Eur J Surg Oncol. 2014. PMID: 24411704
-
Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.J Pak Med Assoc. 2017 Jul;67(7):1121-1123. J Pak Med Assoc. 2017. PMID: 28770902 Review.
-
Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.J Clin Neurosci. 2012 Nov;19(11):1471-4. doi: 10.1016/j.jocn.2012.03.009. Epub 2012 Sep 5. J Clin Neurosci. 2012. PMID: 22959448 Review.
Cited by
-
Efficacy of tumour-treating fields therapy in recurrent glioblastoma: A narrative review of current evidence.Medicine (Baltimore). 2023 Dec 1;102(48):e36421. doi: 10.1097/MD.0000000000036421. Medicine (Baltimore). 2023. PMID: 38050252 Free PMC article. Review.
-
The impact of photodynamic therapy on immune system in cancer - an update.Front Immunol. 2024 Feb 28;15:1335920. doi: 10.3389/fimmu.2024.1335920. eCollection 2024. Front Immunol. 2024. PMID: 38481994 Free PMC article. Review.
-
Advances in optical molecular imaging for neural visualization.Front Bioeng Biotechnol. 2023 Aug 21;11:1250594. doi: 10.3389/fbioe.2023.1250594. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37671191 Free PMC article. Review.
-
Evolution in optical molecular imaging techniques guided nerve imaging from 2009 to 2023: a bibliometric and visualization analysis.Front Neurol. 2025 Jan 22;15:1474353. doi: 10.3389/fneur.2024.1474353. eCollection 2024. Front Neurol. 2025. PMID: 39911740 Free PMC article.
-
Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies.J Neurooncol. 2021 May;152(3):541-549. doi: 10.1007/s11060-021-03723-9. Epub 2021 Mar 4. J Neurooncol. 2021. PMID: 33661424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical